![WL-AAE-ZT-O-391 (TITANIUM DIOXIDE, ZINC OXIDE) LOTION [NANOPHASE TECHNOLOGIES CORPORATION]](https://medic.hrt.org//dailymed/images/77bd9885-55a2-dfae-e053-2991aa0abbe1/WL-AAE-ZT-391.jpg)
| NDC | 63931-4301-1 |
| Set ID | 77bd9885-55a2-dfae-e053-2991aa0abbe1 |
| Category | HUMAN OTC DRUG LABEL |
| Packager | Nanophase Technologies Corporation |
| Generic Name | |
| Product Class | |
| Product Number | |
| Application Number | PART352 |
- WL-AAA-ZT-O-391
-
INGREDIENTS AND APPEARANCE
WL-AAE-ZT-O-391
titanium dioxide, zinc oxide lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63931-4301 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 1 g in 1 g TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 1 g in 1 g Inactive Ingredients Ingredient Name Strength DIMETHICONOL/PROPYLSILSESQUIOXANE/SILICATE CROSSPOLYMER (450000000 MW) (UNII: 9KB5R958PB) 1 g in 1 g Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63931-4301-1 150000 g in 1 DRUM; Type 0: Not a Combination Product 10/16/2018 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part352 10/16/2018 Labeler - Nanophase Technologies Corporation (623502044) Registrant - Nanophase Technologies Corporation (623502044)
